UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 97 filers reported holding UTAH MED PRODS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $605,000 | -3.5% | 7,571 | +7.0% | 0.00% | -25.0% |
| Q2 2020 | $627,000 | +5.9% | 7,077 | +12.5% | 0.00% | -20.0% |
| Q1 2020 | $592,000 | -9.9% | 6,293 | +3.4% | 0.01% | +25.0% |
| Q4 2019 | $657,000 | +33.8% | 6,086 | +18.7% | 0.00% | 0.0% |
| Q3 2019 | $491,000 | +1.9% | 5,127 | +1.8% | 0.00% | 0.0% |
| Q2 2019 | $482,000 | +17.0% | 5,035 | +8.0% | 0.00% | +33.3% |
| Q1 2019 | $412,000 | -12.7% | 4,663 | -17.9% | 0.00% | -40.0% |
| Q4 2018 | $472,000 | +0.2% | 5,683 | +13.8% | 0.01% | +25.0% |
| Q3 2018 | $471,000 | +1.5% | 4,995 | +18.7% | 0.00% | 0.0% |
| Q2 2018 | $464,000 | +13.2% | 4,209 | +1.6% | 0.00% | 0.0% |
| Q1 2018 | $410,000 | -11.3% | 4,143 | -27.0% | 0.00% | -20.0% |
| Q4 2017 | $462,000 | +6.9% | 5,678 | -3.2% | 0.01% | 0.0% |
| Q3 2017 | $432,000 | +51.0% | 5,867 | +48.6% | 0.01% | +25.0% |
| Q2 2017 | $286,000 | +27.1% | 3,947 | +9.3% | 0.00% | +33.3% |
| Q1 2017 | $225,000 | +5.1% | 3,612 | +22.5% | 0.00% | 0.0% |
| Q4 2016 | $214,000 | – | 2,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 40,000 | $4,000,000 | 5.64% |
| Clean Yield Group | 14,474 | $1,447,000 | 0.46% |
| RICE HALL JAMES & ASSOCIATES, LLC | 113,833 | $11,383,000 | 0.40% |
| Ranger Investment Management | 68,730 | $6,873,000 | 0.38% |
| ISTHMUS PARTNERS, LLC | 17,534 | $1,753,000 | 0.29% |
| Cardinal Capital Management | 10,097 | $1,010,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 19,420 | $1,942,000 | 0.20% |
| Ancora Advisors LLC | 26,689 | $2,669,000 | 0.06% |
| Penobscot Investment Management Company, Inc. | 4,000 | $400,000 | 0.05% |
| SEIZERT CAPITAL PARTNERS, LLC | 10,430 | $1,043,000 | 0.05% |